CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types
Bioinformatics · 03.01.2026 · 42 (2)
DOI: 10.1093/bioinformatics/btag022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 14.01.2026. Verfasst von Mengni Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Big Data Research Center, Scientific Research Center, Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research, Department o…. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms, Epigenesis, Genetic, Epigenomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Medical Research Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Motivation Aberrant DNA methylation is a fundamental epigenetic hallmark of cancer. However, existing resources often lack technological diversity and comprehensive cancer coverage. Furthermore, most platforms fail to achieve deep multi-omics integration and tend to ignore cancer-type-specific methylation features, limiting their utility in precision oncology and drug discovery. Results We developed Cancer Methylation Atlas (CMAtlas), a comprehensive platform integrating 13 753 samples across 34 cancer types. By applying technology-tailored pipelines to data from various profiling technologies, we identified 830 725 tumor-specific differentially methylated elements (DMEs) and 1 480 098 differentially methylated regions (DMRs), alongside 1 154 256 cancer-type-specific DMEs and 329 154 DMRs. The platform demonstrates high cross-platform consistency and strong concordance between tumor tissues and cell lines, ensuring the robustness of our findings. All DMEs and DMRs are annotated with multi-omics data (RNA expression, somatic mutations, and chromatin accessibility) and clinical relevance (survival associations and cell-free DNA profiling). We further demonstrate the utility of CMAtlas by identifying prognostic aberrant methylation in colorectal cancer driver genes. Availability and implementation CMAtlas is freely accessible at {{https://cmatlas.renlab.cn/}}. The platform offers an intuitive web interface supporting gene-centric and cancer-centric queries, alongside customizable analysis modules designed to facilitate user-specific research needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Big Data Research Center, Scientific Research Center, Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research, Department of Orthopaedic Surgery, The Seventh Affiliated Hospital of Sun Yat-sen…
- State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.
- The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510182, China.
- Sino-French Hoffmann Institute, Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, Guangdong 510182, China.
ORCID-Profile: Xianping Shi, Yueyuan Zheng
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Shenzhen Science and Technology
- Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research
- Research Start-up Fund of the Seventh Affiliated Hospital
- Sun Yat-sen University
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liu, M., Jiang, L., Zhang, L., Chen, T., Wang, X., Liang, Y., Shi, X., Ren, J., & Zheng, Y. (2026). CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types. Bioinformatics, 42(2). https://doi.org/10.1093/bioinformatics/btag022
Vancouver
Liu M, Jiang L, Zhang L, Chen T, Wang X, Liang Y, et al. CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types. Bioinformatics. 2026;42(2). doi:10.1093/bioinformatics/btag022
BibTeX
@article{Liu2026,
author = {Liu, Mengni and Jiang, Lizhen and Zhang, Luowanyue and Chen, Tianjian and Wang, Xingzhe and Liang, Yuan and Shi, Xianping and Ren, Jian and Zheng, Yueyuan},
title = {CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types},
journal = {Bioinformatics},
year = {2026},
volume = {42},
number = {2},
doi = {10.1093/bioinformatics/btag022}
}
EUVIMED